Decision letter for "Pre‐clinical evaluation of TYK2 inhibitors for human beta cell protection in type 1 diabetes"

2020 ◽  
Keyword(s):  
Type 1 Diabetes ◽  
Beta Cell ◽  
Clinical Evaluation ◽  
Cell Protection ◽  
Beta Cell Protection ◽  
Human Beta Cell

Author response for "Pre‐clinical evaluation of TYK2 inhibitors for human beta cell protection in type 1 diabetes"

2020 ◽  
Author(s):  
Alexandra Coomans de Brachène ◽  
Angela Castela ◽  
Anne Op de Beeck ◽  
Raghavendra G. Mirmira ◽  
Lorella Marselli ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Beta Cell ◽  
Clinical Evaluation ◽  
Author Response ◽  
Cell Protection ◽  
Beta Cell Protection ◽  
Human Beta Cell

scholarly journals Preclinical evaluation of tyrosine kinase 2 inhibitors for human beta‐cell protection in type 1 diabetes

2020 ◽  
Vol 22 (10) ◽  
pp. 1827-1836 ◽  
Author(s):  
Alexandra Coomans de Brachène ◽  
Angela Castela ◽  
Anne Op de Beeck ◽  
Raghavendra G. Mirmira ◽  
Lorella Marselli ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Tyrosine Kinase ◽  
Beta Cell ◽  
Cell Protection ◽  
Preclinical Evaluation ◽  
Tyrosine Kinase 2 ◽  
Beta Cell Protection ◽  
Human Beta Cell

scholarly journals Genome-scale in vivo CRISPR screen identifies RNLS as a target for beta cell protection in type 1 diabetes

2020 ◽  
Vol 2 (9) ◽  
pp. 934-945 ◽  
Author(s):  
Erica P. Cai ◽  
Yuki Ishikawa ◽  
Wei Zhang ◽  
Nayara C. Leite ◽  
Jian Li ◽  
...  
Keyword(s):  
Type 1 Diabetes ◽  
Beta Cell ◽  
Cell Protection ◽  
Crispr Screen ◽  
Beta Cell Protection ◽  
Genome Scale
Sign in / Sign up

Export Citation Format

Share Document